Cargando…
Phage idiotype vaccination: first phase I/II clinical trial in patients with multiple myeloma
BACKGROUND: Multiple myeloma is characterized by clonal expansion of B cells producing monoclonal immunoglobulins or fragments thereof, which can be detected in the serum and/or urine and are ideal target antigens for patient-specific immunotherapies. METHODS: Using phage particles as immunological...
Autores principales: | Roehnisch, Tim, Then, Cornelia, Nagel, Wolfgang, Blumenthal, Christina, Braciak, Todd, Donzeau, Mariel, Böhm, Thomas, Flaig, Michael, Bourquin, Carole, Oduncu, Fuat S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113220/ https://www.ncbi.nlm.nih.gov/pubmed/24885819 http://dx.doi.org/10.1186/1479-5876-12-119 |
Ejemplares similares
-
Chemically linked phage idiotype vaccination in the murine B cell lymphoma 1 model
por: Roehnisch, Tim, et al.
Publicado: (2013) -
A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients
por: Li, Pan, et al.
Publicado: (2017) -
Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival
por: Li, Pan, et al.
Publicado: (2017) -
Impact of age and mismatch repair status on survival in colorectal cancer
por: Li, Pan, et al.
Publicado: (2017) -
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells
por: Roskopf, Claudia C., et al.
Publicado: (2016)